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ABSTRACT 
Alzheimer’s disease is the most common cause of late-life dementia and 
the fourth leading cause of death in the developed world.  The aetiology of 
AD has not yet been resolved.  It has been suggested that AD could result 
from multifactorial process involving both a genetic predisposition and an 
exposure to environmental factors modulated by the biological aging 
process.  To date, epidemiological and molecular genetic data have led to 
the identification of three genes, amyloid precursor protein (APP), 
presenilin 1 (PS1) and presenilin 2 (PS2) genes, which, when mutated, 
can cause an early onset form of AD.  Genetic linkage studies and 
association studies have also shown that the ε4 allele of the apolipoprotein 
E gene increases risk for AD in a dose dependent manner in both early 
onset and late onset AD.  Recently, it has also been suggested that 
environmental factors may interact with a genetic predisposition to modify 
the risk of AD.  Extensive research is underway to identify environmental 
and genetic risk factors for this complex disease.  Over 40 genes have 
been tested as AD candidates yet none has been clearly established as 
an AD risk factor.  Currently scientists are investigating the 
interrelationship between various gene loci and how environmental factors 
could affect an individual’s susceptibility to AD.   
 
This study evaluated the genotoxicity of environmental agents such as 
hydrogen peroxide, cadmium chloride and γ radiation induced oxidative 
DNA damage in lymphocytes and within specific DNA sequences of APP 
(exon 15-18) and PS1 (exon 3-12) genes of AD patients and age-matched 
control subjects.  As indicators of oxidative DNA damage, the frequencies 
of DNA strand breaks, oxidized pyrimidines and altered purines was 
assessed using the alkaline Comet assay modified with lesion-specific 
endonucleases, endo-III and fpg; and fluorescence in situ hybridisation.   
The number of APP and PS1 hybridisation spots per comet were used as 
an indicator of the extent of damage.  The location of the hybridisation 
spots in the head or tail of the comet were recorded to further determine 
 iii
whether the gene of interest lies within or in the vicinity of a damaged 
region of DNA.  With the alkaline Comet assay modified with endo-III and 
fpg, it was demonstrated that patients with AD had significantly increased 
levels of DNA strand breaks, oxidized pyrimidines and altered purines 
induced by hydrogen peroxide, cadmium chloride and γ radiation 
compared with control subjects (p<0.05).  This was further confirmed by 
the fluorescence in situ hybridisation modification of the alkaline Comet 
assay by demonstrating a significant increase in the mean number of APP 
and PS1 gene hybridisation spots per comet in AD patients compared with 
control subjects.  Moreover, the gene sensitivity index of APP and PS1 to 
hydrogen peroxide, cadmium chloride and γ radiation were found to be 
higher in AD patients than in control subjects. 
 
Taken together, our results suggest (i) that lymphocytes from patients with 
AD are sensitive to these environmental genotoxic agents and (ii) there 
was an overall increase in the mean number and sensitivity index of APP 
and PS1 genes to environmental genotoxic agents which might link a 
genetic cause to oxidative stress in peripheral cells of AD patients than in 
control subjects.  Although the mechanisms by which these environmental 
agents induced oxidative DNA damage remained to be elucidated, our 
data suggest that increased oxidative stress is an inherent property of 
cells carrying genes associated with AD. 
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